HALO logo
halo search icon
BioCryst Pharmaceuticals, Inc.
BioCryst Pharmaceuticals, Inc.
BCRX · NAS

BioCryst Pharmaceuticals, Inc.

US$8.37

Price Arrow-0.37 (-4.233%)
21/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusConsensus CheapHALO AllHALO Consensus ValueHALO Price MomentumHammer Bearish
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

BioCryst Pharmaceuticals, Inc. Overview

BCRX Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Weak

Garp

Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Strong

Earnings

Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Neutral

Balance Sheet

Very Weak

About BCRX

icon

Telephone

1.919.859.1302

icon

Address

Suite 200, 4505 Emperor Boulevard, Durham, NC 27703-8457

Description

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

BCRX Price Chart

Key Stats

Market Cap

US$2.22B

PE

6.50

EV/EBITDA

5.5

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 6 - 11.31

Trade Value (12mth)

US$9,063,602.00

1 week

-3.1%

1 month

-3%

YTD

16.53%

1 year

-15.88%

All time high

23.00

Key Fundamentals

EPS 3 yr Growth

-194.60%

EBITDA Margin

39.10%

Operating Cashflow

$330m

Free Cash Flow Return

101.80%

ROIC

81.40%

Interest Coverage

4.30

Quick Ratio

2.00

Other Data

Shares Outstanding (Fully Diluted)

242m

HALO Sector

Healthcare

Next Company Report Date

24-Feb-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

BCRX Announcements

Latest Announcements

DateAnnouncements
07 May 26
06 May 26
06 May 26
04 May 26
04 May 26

BCRX Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-1.18-0.431.26locklocklock
EPS (Fully Diluted)
$locklocklocklock-1.18-0.431.21locklocklock
Growth
%locklocklocklock11.363.5392.3locklocklock
PE
XlocklocklocklockN/AN/A6.5locklocklock
EV/EBITDA
XlocklocklocklockN/AN/A5.5locklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of BioCryst Pharmaceuticals, Inc. (BCRX:NAS)?
Halo FAQ
The current share price of BioCryst Pharmaceuticals, Inc. (BCRX:NAS) is USD$8.37.
What is the 52-week high share price for BioCryst Pharmaceuticals, Inc. (BCRX:NAS)?
Halo FAQ
The 52-week high share price for BioCryst Pharmaceuticals, Inc. (BCRX:NAS) is USD$11.31.
What is the 52-week low share price for BioCryst Pharmaceuticals, Inc. (BCRX:NAS)?
Halo FAQ
The 52-week low share price for BioCryst Pharmaceuticals, Inc. (BCRX:NAS) is USD$6.00.
What is the dividend yield for BioCryst Pharmaceuticals, Inc. (BCRX:NAS)?
Halo FAQ
BioCryst Pharmaceuticals, Inc. (BCRX:NAS) does not pay a dividend.
What was BioCryst Pharmaceuticals, Inc. (BCRX:NAS) last dividend payment?
Halo FAQ
BioCryst Pharmaceuticals, Inc. (BCRX:NAS) does not pay a dividend.
What is the franking level for BioCryst Pharmaceuticals, Inc. (BCRX:NAS)?
Halo FAQ
BioCryst Pharmaceuticals, Inc. (BCRX:NAS) has a franking level of 0.00%.
In which sector is BioCryst Pharmaceuticals, Inc. (BCRX:NAS) classified?
Halo FAQ
BioCryst Pharmaceuticals, Inc. (BCRX:NAS) is classified in the Healthcare.
What is the price-to-earnings (P/E) ratio for BioCryst Pharmaceuticals, Inc. (BCRX:NAS)?
Halo FAQ
The current P/E ratio for BioCryst Pharmaceuticals, Inc. (BCRX:NAS) is 6.50.

See beyond the curve.

One solution for research, investing and portfolio management.